Shah Punit J, Ike Chiamaka, Thibeaux Meghan, Rodriguez Emilyn, Maddox Shermel-Edwards, Daoura Nicolas
Houston Methodist Sugar Land Hospital, Sugar Land, TX, USA.
University of Houston, Sugar Land, TX, USA.
Hosp Pharm. 2021 Aug;56(4):210-214. doi: 10.1177/0018578719888911. Epub 2019 Nov 13.
Antimicrobial therapy for asymptomatic bacteriuria (ASB) is often unnecessary and is a common reason for inappropriate antimicrobial use in hospitalized patients. Unnecessary ASB treatment leads to collateral damage such as resistance, and infections. This study evaluated the impact of interdisciplinary antimicrobial stewardship interventions on antimicrobial utilization in ASB. This was a quasi-experimental institutional review board (IRB)-approved study evaluating the impact of antimicrobial stewardship on antibiotic utilization for ASB in a pilot medical-surgical unit. The control phase was from August-October 2017 and the postintervention phase was from December-March 2018. In the control phase, electronic medical records of patients with positive urine cultures were retrospectively reviewed. Patients were classified as either having ASB or urinary tract infection (UTI) based on the absence or presence of UTI symptoms documented in the medical record. The intervention phase consisted of educational in-services to providers, nurses, and pharmacists. Clinical pharmacists for the pilot unit utilized an electronic real-time surveillance system to identify patients with positive urine cultures. With nurses' collaboration, clinical pharmacists classified these patients as either having UTI or ASB. Stewardship interventions were made in real-time to discontinue antibiotics in patients with ASB. There were 65 and 77 patients with bacteriuria in the pre- and postintervention phases. Among these, ASB was present in 29 (45%) and 27 (35%) patients, respectively. After excluding those receiving antibiotics for concurrent nonurinary indications, the combination of education with pharmacist and nursing interventions decreased unnecessary ASB treatment from 18 (62%) to 6 (22%) patients (relative risk: 0.36, 95% confidence interval: 0.16-0.72, = .003). The findings of this study highlight the importance of interdisciplinary interventions in reducing unnecessary antimicrobial therapy for the treatment of ASB. With increasing antimicrobial resistance, healthcare institutions should evaluate the role of these interdisciplinary interventions to reduce unnecessary treatment for ASB.
无症状菌尿(ASB)的抗菌治疗通常没有必要,且是住院患者抗菌药物使用不当的常见原因。不必要的ASB治疗会导致诸如耐药性和感染等附带损害。本研究评估了跨学科抗菌药物管理干预措施对ASB抗菌药物使用的影响。这是一项经机构审查委员会(IRB)批准的准实验性研究,评估在一个试点内科-外科病房中抗菌药物管理对ASB抗生素使用的影响。对照阶段为2017年8月至10月,干预后阶段为2018年12月至3月。在对照阶段,对尿培养阳性患者的电子病历进行回顾性审查。根据病历中记录的是否存在尿路感染(UTI)症状,将患者分类为患有ASB或UTI。干预阶段包括对医护人员、护士和药剂师的教育在职培训。试点病房的临床药剂师利用电子实时监测系统识别尿培养阳性的患者。在护士的协作下,临床药剂师将这些患者分类为患有UTI或ASB。对ASB患者实时进行管理干预以停用抗生素。干预前和干预后阶段分别有65例和77例菌尿患者。其中,分别有29例(45%)和27例(35%)患者患有ASB。在排除因并发非泌尿系统适应症而接受抗生素治疗的患者后,教育与药剂师及护理干预相结合,使不必要的ASB治疗患者从18例(62%)减少至6例(22%)(相对风险:0.36,95%置信区间:0.16 - 0.72,P = 0.003)。本研究结果凸显了跨学科干预在减少ASB不必要抗菌治疗方面的重要性。随着抗菌药物耐药性的增加,医疗机构应评估这些跨学科干预措施在减少ASB不必要治疗方面的作用。